These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 14596082)

  • 21. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statement for the prevention of vascular disease.
    National Vascular Disease Prevention Alliance
    Aust Fam Physician; 2004 Apr; 33(4):235-9. PubMed ID: 15129468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen.
    Baldassarre S; Schandene L; Choufani G; Michils A
    J Allergy Clin Immunol; 2006 Jan; 117(1):215-7. PubMed ID: 16387610
    [No Abstract]   [Full Text] [Related]  

  • 27. Flecainide: safety and efficacy.
    Somberg JC
    Cardiology; 2008; 111(2):82. PubMed ID: 18376117
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of dextropropoxyphene + acetaminophen fixed-dose combination in psychiatric hospital in Bahrain: is there a cause for concern?
    Al Khaja KA; Al-Haddad MK; Al-Offi AR; Abdulraheem MH; Sequeira RP
    Fundam Clin Pharmacol; 2009 Apr; 23(2):253-8. PubMed ID: 19645819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
    Conter HS; McKay DW; Reiz RJ
    Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
    Fossum E; Moan A; Kjeldsen SE; Devereux RB; Julius S; Snapinn SM; Edelman JM; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Dahlöf B;
    J Am Coll Cardiol; 2005 Sep; 46(5):770-5. PubMed ID: 16139123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
    Marshall DA; Strauss ME; Pericak D; Buitendyk M; Codding C; Torrance GW
    Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator.
    Herrero-Beaumont G; Ivorra JA; Del Carmen Trabado M; Blanco FJ; Benito P; Martín-Mola E; Paulino J; Marenco JL; Porto A; Laffon A; Araújo D; Figueroa M; Branco J
    Arthritis Rheum; 2007 Feb; 56(2):555-67. PubMed ID: 17265490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Clin Geriatr Med; 2006 Feb; 22(1):57-74, viii. PubMed ID: 16377467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and therapeutic goals. What are you actually treating?
    Shakib S; George A
    Aust Fam Physician; 2003 Mar; 32(3):147-9. PubMed ID: 12666353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.